Oncolytics Biotech (ONCY) Misses Q3 EPS by 3c

Oncolytics Biotech (NASDAQ: ONCY) reported Q3 EPS of ($0.14), $0.03 worse than the analyst estimate of ($0.11).

For earnings history and earnings-related data on Oncolytics Biotech (ONCY) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Hermès can regain momentum despite China weakness, Jefferies says
• C.H. Robinson acquires DeSpir Logistics for $75 million